ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,416.45
-0.09%
Dow Jones
39,821.94
0.04%
Gold vs US Dollar
2,420.73
-0.24%
Brent Oil
82.515
-1.22%
Bitcoin
69,780.22
-2.34%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU
  6. Nicox SA (ALCOX)

  7. Nicox SA (ALCOX) News

Nicox (ALCOX)

Nicox SA
Date:
Sort by:
 Showing the most relevant articles for your search:EU:ALCOX
DateTimeSourceHeadlineSymbolCompany
06/05/202416:46GlobeNewswire Inc.Nicox’s Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024EU:ALCOXNicox SA
06/05/202416:46GlobeNewswire Inc.Nicox : assemblée générale ordinaire et extraordinaire du 6 mai 2024EU:ALCOXNicox SA
02/05/202416:45GlobeNewswire Inc.Nombre de droits de vote au 30 avril 2024EU:ALCOXNicox SA
02/05/202416:45GlobeNewswire Inc.Number of voting rights as of April 30, 2024EU:ALCOXNicox SA
24/04/202406:30GlobeNewswire Inc.Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agentEU:ALCOXNicox SA
24/04/202406:30GlobeNewswire Inc.Nicox : Deuxième convocation à l’Assemblée Générale Ordinaire et Extraordinaire le 6 mai 2024 et désignation d’un mandataire ad hocEU:ALCOXNicox SA
22/04/202406:30GlobeNewswire Inc.Nicox Provides First Quarter 2024 Update and Full Year 2023 Financial ResultsEU:ALCOXNicox SA
22/04/202406:30GlobeNewswire Inc.Nicox : Point financier sur le premier trimestre 2024 et résultats financiers de l’année 2023EU:ALCOXNicox SA
09/04/202416:30GlobeNewswire Inc.Nicox: 2024 Ordinary and Extraordinary Shareholder MeetingEU:ALCOXNicox SA
09/04/202416:30GlobeNewswire Inc.Nicox : Assemblée Générale Ordinaire et Extraordinaire 2024EU:ALCOXNicox SA
02/04/202416:45GlobeNewswire Inc.Nombre de droits de vote au 31 mars 2024EU:ALCOXNicox SA
02/04/202416:45GlobeNewswire Inc.Number of voting rights as of March 31, 2024EU:ALCOXNicox SA
22/03/202406:30GlobeNewswire Inc.Nicox's Shareholder LetterEU:ALCOXNicox SA
22/03/202406:30GlobeNewswire Inc.Nicox - Lettre aux ActionnairesEU:ALCOXNicox SA
20/03/202406:30GlobeNewswire Inc.Results from Mont Blanc Phase 3 Trial of Nicox’s NCX 470 in Glaucoma Published in the American Journal of OphthalmologyEU:ALCOXNicox SA
20/03/202406:30GlobeNewswire Inc.Nicox : Publication de résultats de l’étude de phase 3 Mont Blanc sur le NCX 470 dans le glaucome dans la revue American Journal of OphthalmologyEU:ALCOXNicox SA
13/03/202406:30GlobeNewswire Inc.Nicox fait le point sur les perspectives de son développement, de son portefeuille de produits et de son financement et tiendra une réunion par webcast le 18 mars 2024EU:ALCOXNicox SA
13/03/202406:30GlobeNewswire Inc.Nicox Updates on Corporate, Pipeline and Financing Perspectives and Will Hold a Webcast on March 18, 2024EU:ALCOXNicox SA
05/03/202406:30GlobeNewswire Inc.Nicox : Présentation de données sur le NCX 470 au Congrès Annuel 2024 de l’American Glaucoma SocietyEU:ALCOXNicox SA
05/03/202406:30GlobeNewswire Inc.Nicox Announces Presentation of Data on NCX 470 at the 2024 American Glaucoma Society Annual MeetingEU:ALCOXNicox SA
01/03/202416:45GlobeNewswire Inc.Number of voting rights as of February 29, 2024EU:ALCOXNicox SA
01/03/202416:45GlobeNewswire Inc.Nombre de droits de vote au 29 février 2024EU:ALCOXNicox SA
28/02/202406:30GlobeNewswire Inc.Gavin Spencer, dirigeant expérimenté du secteur de la biotechnologie, nommé Directeur Général de NicoxEU:ALCOXNicox SA
28/02/202406:30GlobeNewswire Inc.Nicox Appoints Experienced Biotech Executive Gavin Spencer as CEOEU:ALCOXNicox SA
28/02/202406:30GlobeNewswire Inc.Nicox restructure sa dette et réduit sa structure pour étendre son horizon de trésorerie et prioriser les ressources sur l’étude pivotale sur le NCX 470EU:ALCOXNicox SA
28/02/202406:30GlobeNewswire Inc.Nicox Restructures Debt, Streamlines Operations to Extend Cash Runway and Focus Resources on NCX 470 Pivotal TrialEU:ALCOXNicox SA
08/02/202406:30GlobeNewswire Inc.Nicox : Contrat de licence avec la société Kowa pour le développement et la commercialisation du NCX 470 au JaponEU:ALCOXNicox SA
08/02/202406:30GlobeNewswire Inc.Nicox and Kowa Enter into Agreement for NCX 470 Development and Commercialization in JapanEU:ALCOXNicox SA
06/02/202406:30GlobeNewswire Inc.Nicox announces presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024EU:ALCOXNicox SA
06/02/202406:30GlobeNewswire Inc.Nicox : Présentations au prochain Congrès Annuel 2024 de l’Association for Research in Vision and Ophthalmology (ARVO)EU:ALCOXNicox SA
 Showing the most relevant articles for your search:EU:ALCOX

Your Recent History

USOTC
MCBI
Mountain Comm Bancorp (QX)
USOTC
TOYRF
Toys R Us Anz (PK)
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved